Fig. 1From: A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-19Flow chart. Patients with critical COVID-19 and valid peak and trough values of anti-Factor XaBack to article page